These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 6762978)

  • 1. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 5. [The platelet inhibitor problem].
    Straub PW
    Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention of myocardial infarction.
    Davies JA
    Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin and recurrent myocardial infarction.
    Jones RJ
    JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
    Schöndorf TH
    Med Welt; 1982 Jun; 33(23):851-4. PubMed ID: 7050615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical aspects of antiplatelet therapy.
    Sherry S
    Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.